Skip to content

Clinical trials

Phase 1 Hepatitis B, Chronic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B, Chronic Phase: Phase 1 Clear all

116 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20061
20071
20094
20101
20113
20123
20131
20142
20156
20165
20175
20188
20192
202012
202111
202213
202311
202414
20254
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed73
Terminated12
Recruiting11
Unknown status10
Not yet recruiting5
Active, not recruiting3
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assembly Biosciences9
Hoffmann-La Roche7
Aligos Therapeutics5
Chong Kun Dang Pharmaceutical3
Enyo Pharma3
Janssen Research & Development, LLC3
Jiangsu HengRui Medicine Co., Ltd.3
Sunshine Lake Pharma Co., Ltd.3
Alios Biopharma Inc.2
Antios Therapeutics, Inc2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B, Chronic116
Hepatitis B25
DNA Virus Infections2
Hepatitis2
Hepatitis, Chronic2
Bronchiolitis Obliterans Syndrome1
Carcinoma, Hepatocellular1
Chronic Disease1
Liver Diseases1
Non-alcoholic Fatty Liver Disease1

Trials

Showing 1 to 25 of 116. Each trial links to its page on Pharma Observatory.

16 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.